Lysophosphatidic acid mediates migration of human mesenchymal stem cells stimulated by synovial fluid of patients with rheumatoid arthritis

Biochimica et Biophysica Acta - Molecular and Cell Biology of Lipids

Volumn 1801, Issue 1, 2010, Pages 23-30

  Song, Hae Young ^a   Lee, Mi Jeong ^a   Kim, Min Young ^a   Kim, Kyung Hye ^a   Lee, Il Hwan ^a   Shin, Sang Hun ^a   Lee, Jung Sub ^a   Kim, Jae Ho ^a  

^a Pusan National University School of Medicine   (South Korea)

Author keywords

Arthritis; Lysophosphatidic acid; Mesenchymal stem cell; Migration; Synovial fluid

Indexed keywords

AUTOTAXIN; CALCIUM; CALCIUM CALMODULIN DEPENDENT PROTEIN KINASE II; LENTIVIRUS VECTOR; LYSOPHOSPHATIDIC ACID; LYSOPHOSPHATIDIC ACID RECEPTOR; N (6 AMINOHEXYL) 5 CHLORO 1 NAPHTHALENESULFONAMIDE; N [2 [[N [3 (4 CHLOROPHENYL) 2 PROPENYL] N METHYLAMINO]METHYL]PHENYL] N (2 HYDROXYETHYL) 4 METHOXYBENZENESULFONAMIDE; SHORT HAIRPIN RNA; SMALL INTERFERING RNA;

ADULT; ARTICLE; CALCIUM CELL LEVEL; CELL HOMING; CELL MIGRATION; CLINICAL ARTICLE; CONTROLLED STUDY; ENZYME ACTIVATION; FEMALE; HUMAN; HUMAN CELL; HUMAN CELL CULTURE; IN VITRO STUDY; MALE; MESENCHYMAL STEM CELL; OSTEOARTHRITIS; PRIORITY JOURNAL; RHEUMATOID ARTHRITIS; SYNOVIAL FLUID;

ARTHRITIS, RHEUMATOID; BONE MARROW CELLS; CALCIUM-CALMODULIN-DEPENDENT PROTEIN KINASE TYPE 2; CELL MOVEMENT; CELLS, CULTURED; HUMANS; LYSOPHOSPHOLIPIDS; MESENCHYMAL STEM CELLS; RECEPTORS, LYSOPHOSPHATIDIC ACID; SYNOVIAL FLUID;

EID: 71549130757     PISSN: 13881981     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bbalip.2009.08.011     Document Type: Article

References (53)

1. Feldmann M., Brennan F.M., and Maini R.N. Rheumatoid arthritis. Cell 85 (1996) 307-310
2. Buckley C.D. Michael Mason prize essay 2003. Why do leucocytes accumulate within chronically inflamed joints?. Rheumatology (Oxford) 42 (2003) 1433-1444
3. Scrivo R., Di Franco M., Spadaro A., and Valesini G. The immunology of rheumatoid arthritis. Ann. N. Y. Acad. Sci. 1108 (2007) 312-322
4. Ghosh P., and Guidolin D. Potential mechanism of action of intra-articular hyaluronan therapy in osteoarthritis: are the effects molecular weight dependent?. Semin. Arthritis Rheum. 32 (2002) 10-37
5. Szekanecz Z., Strieter R.M., Kunkel S.L., and Koch A.E. Chemokines in rheumatoid arthritis. Springer Semin. Immunopathol. 20 (1998) 115-132
6. De Bari C., Dell'Accio F., Tylzanowski P., and Luyten F.P. Multipotent mesenchymal stem cells from adult human synovial membrane. Arthritis Rheum 44 (2001) 1928-1942
7. Prockop D.J. Marrow stromal cells as stem cells for nonhematopoietic tissues. Science 276 (1997) 71-74
8. Pittenger M.F., Mackay A.M., Beck S.C., Jaiswal R.K., Douglas R., Mosca J.D., Moorman M.A., Simonetti D.W., Craig S., and Marshak D.R. Multilineage potential of adult human mesenchymal stem cells. Science 284 (1999) 143-147
9. Zuk P.A., Zhu M., Ashjian P., De Ugarte D.A., Huang J.I., Mizuno H., Alfonso Z.C., Fraser J.K., Benhaim P., and Hedrick M.H. Human adipose tissue is a source of multipotent stem cells. Mol. Biol. Cell 13 (2002) 4279-4295
10. Alsalameh S., Amin R., Gemba T., and Lotz M. Identification of mesenchymal progenitor cells in normal and osteoarthritic human articular cartilage. Arthritis Rheum. 50 (2004) 1522-1532
11. Barry F.P., and Murphy J.M. Mesenchymal stem cells: clinical applications and biological characterization. Int. J. Biochem. Cell Biol. 36 (2004) 568-584
12. Short B., Brouard N., Occhiodoro-Scott T., Ramakrishnan A., and Simmons P.J. Mesenchymal stem cells. Arch. Med. Res. 34 (2003) 565-571
13. Jones E.A., English A., Henshaw K., Kinsey S.E., Markham A.F., Emery P., and McGonagle D. Enumeration and phenotypic characterization of synovial fluid multipotential mesenchymal progenitor cells in inflammatory and degenerative arthritis. Arthritis Rheum 50 (2004) 817-827
14. Marinova-Mutafchieva L., Williams R.O., Funa K., Maini R.N., and Zvaifler N.J. Inflammation is preceded by tumor necrosis factor-dependent infiltration of mesenchymal cells in experimental arthritis. Arthritis Rheum 46 (2002) 507-513
15. Tokumura A. Physiological and pathophysiological roles of lysophosphatidic acids produced by secretory lysophospholipase D in body fluids. Biochim. Biophys. Acta 1582 (2002) 18-25
16. Nochi H., Tomura H., Tobo M., Tanaka N., Sato K., Shinozaki T., Kobayashi T., Takagishi K., Ohta H., Okajima F., and Tamoto K. Stimulatory role of lysophosphatidic acid in cyclooxygenase-2 induction by synovial fluid of patients with rheumatoid arthritis in fibroblast-like synovial cells. J. Immunol. 181 (2008) 5111-5119
17. Umezu-Goto M., Kishi Y., Taira A., Hama K., Dohmae N., Takio K., Yamori T., Mills G.B., Inoue K., Aoki J., and Arai H. Autotaxin has lysophospholipase D activity leading to tumor cell growth and motility by lysophosphatidic acid production. J. Cell Biol. 158 (2002) 227-233
18. Xiao Y.J., Schwartz B., Washington M., Kennedy A., Webster K., Belinson J., and Xu Y. Electrospray ionization mass spectrometry analysis of lysophospholipids in human ascitic fluids: comparison of the lysophospholipid contents in malignant vs nonmalignant ascitic fluids. Anal. Biochem. 290 (2001) 302-313
19. Watanabe N., Ikeda H., Nakamura K., Ohkawa R., Kume Y., Aoki J., Hama K., Okudaira S., Tanaka M., Tomiya T., Yanase M., Tejima K., Nishikawa T., Arai M., Arai H., Omata M., Fujiwara K., and Yatomi Y. Both plasma lysophosphatidic acid and serum autotaxin levels are increased in chronic hepatitis C. J. Clin. Gastroenterol. 41 (2007) 616-623
20. Zhao C., Fernandes M.J., Prestwich G.D., Turgeon M., Di Battista J., Clair T., Poubelle P.E., and Bourgoin S.G. Regulation of lysophosphatidic acid receptor expression and function in human synoviocytes: implications for rheumatoid arthritis?. Mol. Pharmacol. 73 (2008) 587-600
21. Birgbauer E., and Chun J. New developments in the biological functions of lysophospholipids. Cell Mol. Life Sci. 63 (2006) 2695-2701
22. Mills G.B., and Moolenaar W.H. The emerging role of lysophosphatidic acid in cancer. Nat. Rev. Cancer 3 (2003) 582-591
23. Tabata K., Baba K., Shiraishi A., Ito M., and Fujita N. The orphan GPCR GPR87 was deorphanized and shown to be a lysophosphatidic acid receptor. Biochem. Biophys. Res. Commun. 363 (2007) 861-866
24. Anliker B., and Chun J. Cell surface receptors in lysophospholipid signaling. Semin. Cell Dev. Biol. 15 (2004) 457-465
25. Murakami M., Shiraishi A., Tabata K., and Fujita N. Identification of the orphan GPCR, P2Y(10) receptor as the sphingosine-1-phosphate and lysophosphatidic acid receptor. Biochem. Biophys. Res. Commun. 371 (2008) 707-712
26. Moolenaar W.H., van Meeteren L.A., and Giepmans B.N. The ins and outs of lysophosphatidic acid signaling. Bioessays 26 (2004) 870-881
27. Lee M.J., Jeon E.S., Lee J.S., Cho M., Suh D.S., Chang C.L., and Kim J.H. Lysophosphatidic acid in malignant ascites stimulates migration of human mesenchymal stem cells. J. Cell Biochem. 104 (2008) 499-510
28. Lee M.J., Song H.Y., Kim M.R., Sung S.M., Jung J.S., and Kim J.H. Oncostatin M stimulates expression of stromal-derived factor-1 in human mesenchymal stem cells. Int. J. Biochem. Cell Biol 39 (2007) 650-659
29. Law R.E., Meehan W.P., Xi X.P., Graf K., Wuthrich D.A., Coats W., Faxon D., and Hsueh W.A. Troglitazone inhibits vascular smooth muscle cell growth and intimal hyperplasia. J. Clin. Invest. 98 (1996) 1897-1905
30. Annabi B., Thibeault S., Lee Y.T., Bousquet-Gagnon N., Eliopoulos N., Barrette S., Galipeau J., and Beliveau R. Matrix metalloproteinase regulation of sphingosine-1-phosphate-induced angiogenic properties of bone marrow stromal cells. Exp. Hematol. 31 (2003) 640-649
31. Kang Y.J., Jeon E.S., Song H.Y., Woo J.S., Jung J.S., Kim Y.K., and Kim J.H. Role of c-Jun N-terminal kinase in the PDGF-induced proliferation and migration of human adipose tissue-derived mesenchymal stem cells. J. Cell Biochem. 95 (2005) 1135-1145
32. Hama K., Aoki J., Fukaya M., Kishi Y., Sakai T., Suzuki R., Ohta H., Yamori T., Watanabe M., Chun J., and Arai H. Lysophosphatidic acid and autotaxin stimulate cell motility of neoplastic and non-neoplastic cells through LPA1. J. Biol. Chem. 279 (2004) 17634-17639
33. Van Leeuwen F.N., Olivo C., Grivell S., Giepmans B.N., Collard J.G., and Moolenaar W.H. Rac activation by lysophosphatidic acid LPA1 receptors through the guanine nucleotide exchange factor Tiam1. J. Biol. Chem. 278 (2003) 400-406
34. Yamada T., Sato K., Komachi M., Malchinkhuu E., Tobo M., Kimura T., Kuwabara A., Yanagita Y., Ikeya T., Tanahashi Y., Ogawa T., Ohwada S., Morishita Y., Ohta H., Im D.S., Tamoto K., Tomura H., and Okajima F. Lysophosphatidic acid (LPA) in malignant ascites stimulates motility of human pancreatic cancer cells through LPA1. J. Biol. Chem. 279 (2004) 6595-6605
35. Shida D., Kitayama J., Yamaguchi H., Okaji Y., Tsuno N.H., Watanabe T., Takuwa Y., and Nagawa H. Lysophosphatidic acid (LPA) enhances the metastatic potential of human colon carcinoma DLD1 cells through LPA1. Cancer Res 63 (2003) 1706-1711
36. Dwyer R.M., Potter-Beirne S.M., Harrington K.A., Lowery A.J., Hennessy E., Murphy J.M., Barry F.P., O'Brien T., and Kerin M.J. Monocyte chemotactic protein-1 secreted by primary breast tumors stimulates migration of mesenchymal stem cells. Clin. Cancer Res. 13 (2007) 5020-5027
37. Ji J.F., He B.P., Dheen S.T., and Tay S.S. Interactions of chemokines and chemokine receptors mediate the migration of mesenchymal stem cells to the impaired site in the brain after hypoglossal nerve injury. Stem Cells 22 (2004) 415-427
38. Li C., Kong Y., Wang H., Wang S., Yu H., Liu X., Yang L., Jiang X., Li L., and Li L. Homing of bone marrow mesenchymal stem cells mediated by sphingosine 1-phosphate contributes to liver fibrosis. J. Hepatol. 50 (2009) 1174-1183
39. Ponte A.L., Marais E., Gallay N., Langonne A., Delorme B., Herault O., Charbord P., and Domenech J. The in vitro migration capacity of human bone marrow mesenchymal stem cells: comparison of chemokine and growth factor chemotactic activities. Stem Cells 25 (2007) 1737-1745
40. Ridderstad A., Abedi-Valugerdi M., and Moller E. Cytokines in rheumatoid arthritis. Ann. Med. 23 (1991) 219-223
41. Iwamoto T., Okamoto H., Toyama Y., and Momohara S. Molecular aspects of rheumatoid arthritis: chemokines in the joints of patients. FEBS J 275 (2008) 4448-4455
42. Lundberg M.S., Curto K.A., Bilato C., Monticone R.E., and Crow M.T. Regulation of vascular smooth muscle migration by mitogen-activated protein kinase and calcium/calmodulin-dependent protein kinase II signaling pathways. J. Mol. Cell Cardiol. 30 (1998) 2377-2389
43. Pauly R.R., Bilato C., Sollott S.J., Monticone R., Kelly P.T., Lakatta E.G., and Crow M.T. Role of calcium/calmodulin-dependent protein kinase II in the regulation of vascular smooth muscle cell migration. Circulation 91 (1995) 1107-1115
44. Zhang S., Yang Y., Kone B.C., Allen J.C., and Kahn A.M. Insulin-stimulated cyclic guanosine monophosphate inhibits vascular smooth muscle cell migration by inhibiting Ca/calmodulin-dependent protein kinase II. Circulation 107 (2003) 1539-1544
45. Fuchs B., Schiller J., Wagner U., Hantzschel H., and Arnold K. The phosphatidylcholine/lysophosphatidylcholine ratio in human plasma is an indicator of the severity of rheumatoid arthritis: investigations by 31P NMR and MALDI-TOF MS. Clin. Biochem. 38 (2005) 925-933
46. Endres M., Neumann K., Haupl T., Erggelet C., Ringe J., Sittinger M., and Kaps C. Synovial fluid recruits human mesenchymal progenitors from subchondral spongious bone marrow. J. Orthop. Res. 25 (2007) 1299-1307
47. Jones E.A., Crawford A., English A., Henshaw K., Mundy J., Corscadden D., Chapman T., Emery P., Hatton P., and McGonagle D. Synovial fluid mesenchymal stem cells in health and early osteoarthritis: detection and functional evaluation at the single-cell level. Arthritis Rheum. 58 (2008) 1731-1740
48. Neidhart M., Seemayer C.A., Hummel K.M., Michel B.A., Gay R.E., and Gay S. Functional characterization of adherent synovial fluid cells in rheumatoid arthritis: destructive potential in vitro and in vivo. Arthritis Rheum. 48 (2003) 1873-1880
49. Djouad F., Bony C., Haupl T., Uze G., Lahlou N., Louis-Plence P., Apparailly F., Canovas F., Reme T., Sany J., Jorgensen C., and Noel D. Transcriptional profiles discriminate bone marrow-derived and synovium-derived mesenchymal stem cells. Arthritis Res. Ther. 7 (2005) R1304-R1315
50. Yoshimura H., Muneta T., Nimura A., Yokoyama A., Koga H., and Sekiya I. Comparison of rat mesenchymal stem cells derived from bone marrow, synovium, periosteum, adipose tissue, and muscle. Cell Tissue Res. 327 (2007) 449-462
51. Li X., and Makarov S.S. An essential role of NF-kappaB in the "tumor-like" phenotype of arthritic synoviocytes. Proc. Natl. Acad. Sci. U. S. A. 103 (2006) 17432-17437
52. Dowthwaite G.P., Bishop J.C., Redman S.N., Khan I.M., Rooney P., Evans D.J., Haughton L., Bayram Z., Boyer S., Thomson B., Wolfe M.S., and Archer C.W. The surface of articular cartilage contains a progenitor cell population. J. Cell Sci. 117 (2004) 889-897
53. Zhang S., Muneta T., Morito T., Mochizuki T., and Sekiya I. Autologous synovial fluid enhances migration of mesenchymal stem cells from synovium of osteoarthritis patients in tissue culture system. J. Orthop. Res. 26 (2008) 1413-1418